Radioligand therapy in prostate cancer

  • Interview

Dr. Silke GillessenUniv. of Manchester / The Christie

Take-home:

The APCCC chairs break down the congress’s radioligand session and the debates heading to APCCC 2026 in Lugano.

Type
Interview
Published

More on genitourinary cancers